US Stock MarketDetailed Quotes

SPRB Spruce Biosciences

Watchlist
  • 0.754
  • +0.010+1.32%
Close May 6 16:00 ET
  • 0.752
  • -0.002-0.32%
Post 19:52 ET
31.04MMarket Cap-608P/E (TTM)

About Spruce Biosciences Company

Spruce Biosciences, Inc. is a late-stage biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. It focuses on developing its wholly owned product candidate, Tildacerfont. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Company Profile

SymbolSPRB
Company NameSpruce Biosciences
Listing DateOct 9, 2020
Issue Price15.00
Founded2014
CEODr. Javier Szwarcberg, M.D.
MarketNASDAQ
Employees29
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address611 Gateway Boulevard,Suite 740
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-415-655-4168
Websitehttp://www.sprucebio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Javier Szwarcberg, M.D.
  • Chief Executive Officer and Director
  • 2.16M
  • Samir M. Gharib
  • Chief Financial Officer, Principal Accounting Officer and President
  • 1.20M
  • Ralph William Charlton, III,M.D.
  • Chief Medical Officer
  • 1.00M
  • Michael Grey
  • Executive Chairman of the Board
  • 119.39K
  • Camilla V. Simpson, M.Sc.
  • Independent Director
  • 98.39K
  • Dr. Bali Muralidhar, M.D.,PhD
  • Independent Director
  • 94.39K
  • Percival Barretto-Ko
  • Independent Director
  • 127.84K
  • Dr. Tiba Aynechi, PhD
  • Independent Director
  • 99.39K
  • Dr. Kirk Ways, M.D.
  • Independent Director
  • 95.87K
  • Daniel K. Spiegelman
  • Independent Director
  • 106.89K
  • Dr. Niall O’Donnell, PhD
  • Independent Director
  • 96.89K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg